Sudhamshu K-C, Matsutani Shoiichi, Maruyama Hitoshi, Akiike Taro, Saisho Hiromitsu
Liver Unit, Department of Medicine, Bir Hospital, National Academy of Medical Sciences, Kathmandu, Nepal.
World J Gastroenterol. 2006 Sep 28;12(36):5853-8. doi: 10.3748/wjg.v12.i36.5853.
To elucidate the significance of Doppler measurements of hepatic vein in cirrhotic patients and to correlate with liver dysfunction and hepatic hemodynamics.
One hundred patients with liver cirrhosis and 60 non-cirrhotic controls were studied. Doppler waveforms were obtained from right hepatic vein and flow velocity measured during quiet respiration. Doppler measurements were also obtained from portal trunk, right portal vein and proper hepatic artery.
Hepatic vein waveforms were classified into three classical patterns. Flat waveform was uncommon. Mean hepatic vein velocity was significantly higher in cirrhotic patients (12.7 +/- 6.4 vs 5.1 +/- 2.1 and 6.2 +/- 3.2 cm/s; P<0.0001). The poorer the grade of cirrhosis, the higher was the mean velocity. Maximum forward velocity was never greater than 40 cm/s in controls. Degree of ascites was found to be highly correlated with mean velocity. "Very highq group (>=20 cm/s) presented clinically with moderate to massive ascites. Correlations between right portal flow and mean velocity was significant (P<0.0001, r = 0.687).
Doppler waveforms of hepatic vein, which is independent of liver dysfunction, should be obtained during normal respiration. Mean hepatic vein velocity reflects the change in hepatic circulation associated with progression of liver cirrhosis. It can be used as a new parameter in the assessment of liver cirrhosis.
阐明肝硬化患者肝静脉多普勒测量的意义,并将其与肝功能障碍及肝脏血流动力学相关联。
对100例肝硬化患者和60例非肝硬化对照者进行研究。在安静呼吸期间获取右肝静脉的多普勒波形并测量流速。还从门静脉主干、右门静脉和肝固有动脉获取多普勒测量值。
肝静脉波形分为三种典型模式。平坦波形不常见。肝硬化患者的平均肝静脉流速显著更高(分别为12.7±6.4与5.1±2.1以及6.2±3.2 cm/s;P<0.0001)。肝硬化程度越差,平均流速越高。对照组的最大正向流速从未超过40 cm/s。发现腹水程度与平均流速高度相关。“非常高”组(≥20 cm/s)临床上表现为中度至大量腹水。右门静脉血流与平均流速之间的相关性显著(P<0.0001,r = 0.687)。
应在正常呼吸期间获取与肝功能障碍无关的肝静脉多普勒波形。平均肝静脉流速反映了与肝硬化进展相关的肝循环变化。它可作为评估肝硬化的一个新参数。